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Introduction: Smokeless tobacco (ST) was consumed by 356 million people globally in 2017. 
Recent evidence shows that ST consumption is responsible for an estimated 652,494 all-cause deaths 
across the globe annually. The WHO FCTC was negotiated in 2003 and ratified in 2005 to implement 
effective tobacco control measures. While the policy measures enacted through various tobacco 
control laws have been effective in reducing the incidence and prevalence of smoking, the impact of 
ST-related policies (within WHO FCTC and beyond) on ST use is under-researched and not collated.  
Methods and Analysis: A systematic review will be conducted to collate all available ST related 
policies implemented across various countries and assess their impact on ST use. The following 
databases will be searched: Medline, EMBASE , PsycINFO, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Scopus, EconLit, ISI Web of Science, Cochrane Library (CENTRAL), 
African Index Medicus (AIM), LILACS, Scientific Electronic Library Online (SciELO), Index 
Medicus for the Eastern Mediterranean Region (IMEMR), Index Medicus for South-East Asia Region 
(IMSEAR), Western Pacific Region Index Medicus (WPRIM), and WHO Library Database 
(WHOLIS); as well as Google search engine and country-specific government websites. All ST 
related policy documents (FCTC and non-FCTC) will be included. Results will be limited to literature 
published since 2005 in English and regional languages (Bengali, Hindi and Urdu). Two reviewers 
will independently employ two-stage screening to determine inclusion. The Effective Public Health 
Practice Project (EPHPP)’s “Quality Assessment Tool for Quantitative Studies” will be used to record 
ratings of quality and risk of bias among studies selected for inclusion. Data will be extracted using 
a standardised form. Meta-analysis and narrative synthesis will be used. 
Ethics and Dissemination: Permission for ethics exemption of the review was obtained from the 
Centre for Chronic Disease Control’s Institutional Ethics Committee, India (CCDC_IEC_06_2020; 
dated 16 April 2020). The results will be disseminated through publications in a peer-reviewed 
journal and will be presented in national and international conferences.  
 











Strengths and limitations of the study: 
● This is a protocol for a systematic review that is a comprehensive global review of all available 
ST related policies. 
● The review will include all available ST related policies (FCTC and non-FCTC policies). It 
will also include ST policies notified/enforced by various government bodies such as Ministry 
of Health, Ministry of Finance, Ministry of Commerce etc..  
● This review is the first attempt to search for ST related policies globally and assess their 
impact systematically across academic databases and country-specific government websites.  
● Studies and policy documents in English and regional languages for which expertise is 
available in the team (Bangla, Hind, and Urdu) will be included in the review. Due to limited 


























Tobacco products are broadly classified into two categories – smoked and smokeless tobacco (ST). 
The World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) defines 
ST as “tobacco that is consumed in un-burnt form either orally or nasally”.1 A wide range of ST 
products are manufactured and consumed worldwide, some of which are snus, pan masala, gutkha, 
mawa, khaini, zarda, mishri, dry snuff, moist snuff etc. ST was consumed by 356 million people 
globally in 2017.2 Cumulatively, it is estimated that, globally, a total of 652,494 people die from ST 
attributed diseases annually.3 It is used in about 116 countries around the world4, and a vast majority 
of users reside in South and South-East Asia, which bears more than 85% of the burden of diseases 
due to ST use.5 The practice of ST use is culturally influenced and widespread in this region, where 
one-third of tobacco is consumed in the smokeless form.6 This widespread use of ST products is a 
cause for alarm, considering that they have been known to contain more than 30 carcinogens.6 The 
INTERHEART study, a large case-control study published in 2006 and undertaken in 52 countries, 
found that 4.7 million DALYs were lost and 204,309 people died from coronary heart diseases caused 
by ST consumption.7 ST use leads to oral sub-mucous fibrosis and cancers of the oral cavity.8 
Pregnant women using ST have shown a threefold increased risk of stillbirth and two- to threefold 
increased risk of having low-birth-weight babies.9–11  
 
The WHO FCTC was negotiated in 2003, and ratified in 2005, with the aim of providing guidelines 
to implement effective tobacco control measures.1 Currently, there are 183 country-level signatories 
to this treaty. Though the menace of ST use is considered to be relevant  to fewer countries and 
regions than smoking, it is evident that there has been an increase in the prevalence of ST use, even 
in economically-developed countries.12 However, the situation is worse in low- and middle-income 
countries (LMICs), such as India, where the prevalence of ST use is higher than smoking.13 While 
10.7% of all the adults in India are smokers, 21.4%  are current ST users.13 Similarly in Bangladesh, 
while 18% of all adults are smokers, 20.6% are ST users.14 
 
Furthermore, while the policies described under FCTC have been successful in decreasing the 
incidence and prevalence of smoking, there is insufficient evidence on the impact of the same on ST 
use.2 For example, taxation and smoke-free policies (as described in Article 6 of the FCTC) have 
been successful in reducing the prevalence of smoking in countries such as Greece.15 However, the 
impact of these policies on ST use is not widely known, nor have they been systematically collated. 
This could be attributed to the fact that ST has not been given the same importance as smoking while 
implementing these policies. In addition, these policies have often been based on evidence gathered 
5 
 
from research on cigarettes conducted in high-income countries, and hence the translation of the same 
policies for the control of ST in LMICs has not been contextualised.16 For instance, mass media 
campaigns for raising awareness on ST have been highlighted by very few countries, and sale of ST 
products to minors is illegal only in a handful of the countries.2,17 In addition, second hand impact of 
ST use (such as diseases linked to spitting) and its adverse environmental impacts due to disposal of 
small sachets of ST products) do not invoke any public health response. The burden of ST is now 
being realized in some developed countries too. For example, Australia recently imposed a ban on 
import, production, sale, distribution and advertisement of ST products, including chewing tobacco, 
oral snuff, tobacco paste and powder.18 On the other hand,  in the United States of America, the Food 
and Drug Administration (FDA)  now considers ST as a modified risk tobacco product, under their 
Family Smoking Prevention and Tobacco Control Act  2009.12 This change in policy scenario has 
been neither persistent nor uniform across the world. Countries like India and Sri Lanka have gone 
beyond FCTC to include the prohibition of some (e.g. gutka) or all ST products.19 The impact of 
FCTC policies, as well as country-specific tobacco control laws, on the consumption of ST is under-
researched and not collated. 
 
Aims and Objectives 
The study aims to undertake a systematic review to collate all policies implemented across countries 
globally relevant to the control of ST products and assess their impact on ST use.  
 
Specific review questions include: 
Review Question 1 (RQ1): What are the existing policies and legislation (FCTC and non-FCTC) 
related to the control of ST products across various countries globally?   
Review Question 2 (RQ2): What is the impact of these policies on controlling ST use, including its 
uptake, quit and reduction? 
 
Methodology 
The study is a systematic review which will consider all relevant studies from 2005 onwards (after 
the WHO FCTC came into force) without any geographical restriction. Articles in English and for 
which linguistic expertise is available within the team (Bengali, Hindi and Urdu) will be included. 
Our study will include published articles (including commentaries and editorials) searched through 
scientific databases. Policy documents (policies/laws/notifications/Acts related to ST) identified 
through grey literature searches will also be included in the review. Systematic reviews will be 
excluded because we expect to cover most of the relevant literature through our searches and a review 
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of systematic reviews will be beyond the scope of the study. Studies reporting at least one of the 
outcomes (detailed below) in relation to at least one policy of interest will be eligible for inclusion. 
We will identify studies using keywords such as ‘’smokeless tobacco’’, ‘‘public policies’’, etc., with 
synonyms, and based on the PICOS criteria outlined below: 
 
Population: We will include studies on ST users (not e-cigarettes and other nicotine products-
Electronic Nicotine Delivery Systems (ENDS)) of all age groups. 
 
Interventions: Policy documents (FCTC and non-FCTC) within health and other sectors (commerce, 
finance, etc.) that describe the regulation or prohibition of ST products directly or indirectly will be 
considered eligible for RQ1. In addition, only those policies which have been implemented/enforced 
by the government will be included in the study for analysis. Policies which are at the planning stage 
(not implemented/enforced) until June 2020 will not be included. Specifically, we will include 
policies/legislations notified and enforced by governmental bodies such as Ministry of Health, 
Ministry of Finance etc., at the country-level. Documents related to the following policies will be 
included in the review:                
 
FCTC Policies 
● Pricing and taxation (Article 6) 
● Product regulation (Article 9 and 10) 
● Packaging and health warnings (Article 11)  
● Education, communication, training, and public awareness (Article 12)  
● Advertisement, promotion and sponsorship bans (Article 13)  
● Cessation (Article 14) 
● Illicit trade (Article 15)  
● Sales to and by minors (Article 16)  
 
Non-FCTC Policies 
● Complete or partial ban on ST products (e.g. gutkha ban) 
● Import ban 
● Other policies mentioned to control ST (agriculture, environment etc.)  
 
For RQ2, studies that report on the impact of the above-mentioned policies on ST related outcomes 
(see below) will be included.  
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We will exclude studies primarily looking at policies on harm reduction or switching between tobacco 
products. However, if the primary focus of studies is ST cessation then these studies will be 
considered eligible.  
 
Comparators: Absence of intervention or usual care will be considered as comparators.  
 
Outcomes: The outcomes to be included in the review will depend on the research questions. While 
RQ1 will be descriptive and will collate all policy measures undertaken in various countries, RQ2 
will focus on studies reporting any of the following outcome measures in relation to specific policies 
(FCTC and non-FCTC).  
a. Primary outcomes 
 Percentage change in prevalence of ST use 
 Rates of quitting ST (proportion of those who stopped out of total intervened)  
 Percentage change in ST initiation (from never used to ever used)  
 Change in health outcomes for cancers and cardiovascular diseases attributable to ST (ST-
related disease burden is substantial for these conditions, as noted in a recent study).20 
b. Intermediate outcomes 
● ST availability, affordability and accessibility 
● Change in knowledge, attitude, perception and norms related to ST use 
● Change in levels of chemical constituents 
● Noticing health warnings/advertisements 
● Recall of awareness campaigns 
c. Reported unintended effects 
 
Study Design: For RQ1, we will include policy documents, studies, editorials and commentaries. For 
RQ2, observational (cross-sectional/cohort/case-control) and intervention studies (randomized 
controlled trials/quasi experimental studies/economic evaluations) will be included in the review.  
 
Databases 
1. For published studies: The following global and regional databases will be searched to identify 
relevant published studies: Medline, EMBASE, PsycINFO, Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), Scopus, EconLit, ISI Web of Science, Cochrane Library 
(CENTRAL), African Index Medicus (AIM), LILACS, Scientific Electronic Library Online 
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(SciELO), Global Medicus Index (which includes Index Medicus for the Eastern Mediterranean 
Region (IMEMR), Index Medicus for South-East Asia Region (IMSEAR), African Index 
Medicus (AIM) and Western Pacific Region Index Medicus (WPRIM)), and WHO Library 
Database (WHOLIS).  
 
2. For grey literature: Grey literature search will be conducted on two different platforms as 
follows:  
a. Google search engine (first 100 hits) and target websites known within the research team 
such as WHO, Campaign for Tobacco Free Kids (CTFK), International clinical trials registry 
platform (WHO), EU Clinical Trials Register, ISRCTN, ProQuest, or those identified 
through Google search; and 
b. Country-specific government websites will be searched to collate policy documents 
(policies/laws/notifications/Acts) related to ST (FCTC and non-FCTC) in four South Asian 
countries (Bangladesh, India, Pakistan and Sri Lanka).  The ministry websites searching will 
be restricted to South Asian countries only, given the timeframe and scope of the current 
study as well as due to language limitations. We will search websites of the Ministry of 
Health, Ministry of Commerce, Ministry of Finance, Ministry of Environment and 
governmental bodies that might be relevant to either of the four countries.  
 
Search Strategy 
1. For published studies: The literature search will be conducted with key terms such as “smokeless 
tobacco”, “policies”, “legislation”, etc., with their synonyms (search string attached as 
Supplementary file 1. We will identify all ST control policies from around the world to address 
RQ1. For RQ2, from the same search, we will include studies that have estimated impact on ST 
use.  
References from other systematic reviews and chapters/textbooks will be assessed to identify 
potential studies, in addition to hand-searching reference lists and citations of included studies. 
 
2. For grey Literature: Keywords including “smokeless tobacco” and “public policy” along with 
their relevant synonyms will be used to run the grey literature search. Key terms will be in 
alignment with the search terms of the literature review, however, will be adapted to the specific 
contexts of the search engines (google search engine or ministry website search engine). 
a. Google search engine: Google search engine will be used to search ST related documents 
published on the Internet. During our search, the first 100 hits or hits for results going back 
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till the year 2005 (whichever comes first) will be screened for inclusion in the study. The 
results will be assessed using the title and the short description underneath, and all relevant 
records will be bookmarked in the browser and also entered into an Excel spreadsheet. Each 
entry will be made under the heading which has been titled as per the search strategy used. If 
the results include documents from India, Pakistan, Sri Lanka or Bangladesh, they will be 
saved in a separate excel spreadsheet to check for duplicates from the Ministry website 
searches. Newspaper articles will only be screened for identifying ST policies or their impact 
evaluation. Further, potential websites (such as WHO, CTFK) will be identified by Google 
search to identify ST policies or impact assessment studies related to ST policies. The dates 
of searching these websites will be documented in an excel spreadsheet. For the websites with 
a search engine, keywords will be used for searching the documents. For the websites without 
a search engine, hand searching will be conducted to identify relevant policies or impact 
assessment studies. The name, year and URL of these individual records within the websites 
would also be documented in the excel spreadsheet, as a sub-heading of the main website. All 
relevant entries that satisfy the inclusion criteria will then be screened.   
b. Country-specific government websites: A search using keywords, ‘‘smokeless tobacco” and 
“public policy”, with country-specific synonyms will be conducted on government websites 
across four SEAR countries (Bangladesh, India, Pakistan and Sri Lanka). All policy 
documents (policies, laws, legislations, acts and notifications) related to ST (FCTC and non-
FCTC) will be searched on relevant ministry websites. Country level experts on the team who 
have experience in ST research will be consulted to select relevant policy documents from the 
searches. Only national level documents will be selected for this analysis as these policy 
guidelines prescribe the characteristics for sub-national policies. The title and summary of the 
policy documents will be screened. Details of potentially relevant records from all four 
countries will be added into an excel spreadsheet for full-text screening. Relevant policy 
documents after full-text screening and de-duplication with google search results, will be 
included in the review. 
 
To avoid duplication of the work and ensure comparable approaches, regular meetings to discuss 
search strategies among the team will be held.  
 
Study records 
Data management: Records from scientific databases will be imported into CADIMA 




Study Selection: All the studies identified through database searching and policy documents 
identified through grey literature searches will be assessed by two reviewers independently for 
inclusion in the review based on predefined inclusion criteria (stage 1: titles and/or abstracts, stage 2: 
full text). Any disagreement will be resolved through mutual discussion and if needed, through a third 
reviewer.  
Data extraction: Data extraction procedures will follow Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines. A standardised data extraction form (attached as 
Supplementary File 3) will be used to extract data from the included policy documents and studies. 
The extracted information will include: study setting; location; year/s; population; participant 
demographics and baseline characteristics; details of the policies (policy specific to which Article of 
FCTC or whether beyond FCTC) and comparator conditions; study design; sample size and study 
completion rates; outcomes and times of measurement; information for assessment of the risk of bias 
and strength of evidence. Data extraction will be done by two reviewers independently. Missing data 
will be requested from study authors.  
 
Quality assessment  
Critical appraisal will be conducted only for academic publications literature, for which we will use 
the Effective Public Health Practice Project (EPHPP) “Quality Assessment Tool for Quantitative 
Studies”.21,22 The tool will assess study quality on eight domains: selection bias, study design, 
confounders, blinding, data collection methods, withdrawals and drop-outs, intervention integrity, 
analyses. It also gives an overall global rating of weak/moderate/strong evidence, which will be used 
for sensitivity analyses for RQ2.  
 
Data Synthesis 
For RQ1:  Identified policies will be listed according to the focus of the intervention and the target 
population.  
 
Focus of intervention: grouped as 'FCTC and non-FCTC' policies.  
Target population: A further grouping by 'children/youth' and 'adults' will be applied.   
 
Identified policies will be described using the TiDieR checklist for completion and understanding of 
the context; presented in a tabular form.23 Conclusions will be drawn in relation to the review question 
and adequacy of description of the policies across the groupings (Tobacco specific and non-specific; 
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children/youth and adults), summarised narratively to highlight gaps in existing policies for ST 
control. 
 
For RQ 2: Key study characteristics (e.g., study design, population, location, risk of bias) will be 
presented in a tabular form. We will conduct a meta-analysis on the primary outcomes, if:  
i) 2 or more studies are identified for the particular outcome, and  
ii) Heterogeneity in reported effects (I-squared) is less than 50%24 
 
Meta‐analyses will be conducted using a fixed‐effect model, unless there is evidence of between‐
study heterogeneity.25 Where heterogeneity is >=50% we will explore possible explanations using 
sub-group analysis, and will not report a pooled estimate of the effect. Heterogeneity (if more than 
50% for any specific outcome) will be explored visually using tables and forest plots, by comparing 
the effect sizes of studies grouped according to potential effect modifiers. These include: 
1. Focus of intervention (e.g. FCTC or non-FCTC, etc.); 
2. Target population (e.g. children, youth, adults, elderly, etc.) 
3. Quality of studies. 
 
We will assess the publication bias by using Begg's funnel plot by visual inspection for asymmetry.  
Intermediate outcomes (where available for the identified policies) will be described and 
compared narratively across the tobacco specific and non-specific policies as well as by the target 
age of the population (children/youth and adults). The ST context and unintended consequences will 
also be synthesised narratively using a pre-designed conceptual framework on the major influences 
of the tobacco industry, governments and society on ST context (and their interactions); and the 
interaction between individual factors and ST use context to shape its uptake and consumption.  
 
Context 
We will extract any context related information from the papers on the following: physical, 
sociocultural, political (e.g. existence of FCTC and years of implementation) and economic aspects. 
We will also examine any unintended consequences of policies on switching from smoking to ST 
products, where data allows. We will use the framework (Figure 1), for a narrative synthesis of the 
contextual elements that are identified from our included studies. 
 
The INFORMAS framework26 was used for contextualising the basis of this study because it is one 
of the most frequently used frameworks covering the complex interaction between industry, 
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government and society. It is highly evidence-based but equally flexible and can be adapted to other 
lifestyles such as ST consumption. In addition, it helps to identify the key factors that play a role in 
explaining the behavior of individuals and the population and to find ways to modify population 
behavior. Although it is not a system map, it can be used as a basis for identifying the main influences. 
It also allows comparisons to be made between countries and between other areas of research 
concerned with healthy lifestyles, such as obesity prevention and physical activity. It also allows the 
transfer of results and helps to identify context-specific and best practice approaches and supports the 
development and design of policies based on national context. 
 
The ST context framework follows the socio-behavioural theory and a basic premise of this theory is 
that people learn not only through their own experiences, but also by observing the actions of others 
and the results of those actions.27 This is particularly relevant to ST use, which unlike individual 
smoking behaviour in combustible tobacco forms, is a socio-traditionally influenced behaviour.28,29 
ST consumption is unique in certain regions, such as South Asia, not only because of its traditional 
heritage and socio-cultural myths that promote consumption but also the variety of products from 
homemade or small scale production to imported licenced as well as illegal products that are 
logistically and politically challenging to regulate. Individuals, with their personal factors such as 
habits, preferences, education and income, interact with the context that determine their use of these 
products.  
 
The context of ST and each of its component dimensions - physical (e.g. availability, quality, 
promotion), economic (e.g. costs, affordability), policy (e.g. laws, regulations and accessibility) and 
socio-cultural (e.g. norms and beliefs) - has substantial impact on uptake and consumption. Tobacco 
industry, governments and society can influence and shape these dimensions of ST context, thus 
playing a vital role in the uptake and consumption patterns of individuals. These external factors not 
only interact with each other but also interact with the individuals preferences, attitudes, habits and 
income etc. to shape their ST use behaviour. For example, governments, at international, national and 
local levels, through their policies, laws and regulations, provide the ‘rules’ within which the tobacco 
manufacturing and sales sector must operate. Through fiscal policies, such as taxation on tobacco 
sales and subsidies to tobacco growers, governments can influence tobacco product production and 
prices, and, through health promotion and social marketing, they can also influence sociocultural 
norms. Society, through its traditional, cultural and religious practices, predominantly establishes the 





The protocol for this review is published on PROSPERO (dated July 2nd 2020, Version 2).30 Searches 
on the databases mentioned in the protocol were conducted during April-May 2020, following which 
title and abstract screening for scientific literature was done from July-August 2020. We are planning 
to conduct the full-text screening in October-November 2020 and hold on the data extraction till the 
protocol is published.  
 
Ethics and Dissemination Plan 
As this study will be a review of published or publicly available data, there are no ethical concerns 
related to the involvement of humans or any other. Permission for ethics exemption of the review 
was obtained from the Centre for Chronic Disease Control’s Institutional Ethics Committee, India 
(CCDC_IEC_06_2020; dated 16 April 2020). Data will be collected from publicly available scientific 
or grey literature through above-mentioned databases. On completion of the review, we will prepare 
a manuscript for publication in a peer-reviewed journal and present results in national and 
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